SBC Medical Group Holdings Incorporated
SBC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.55 | 0.02 | 0.19 |
| FCF Yield | -4.73% | -1.84% | 0.36% | -1.38% |
| EV / EBITDA | 17.97 | 24.12 | 6.59 | 65.46 |
| Quality | ||||
| ROIC | 3.86% | 1.00% | 6.84% | 2.25% |
| Gross Margin | 68.97% | 69.21% | 79.73% | 76.25% |
| Cash Conversion Ratio | -1.63 | -3.39 | 0.09 | -1.12 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.80% | 30.89% | 66.46% | 5,900,249.90% |
| Free Cash Flow Growth | -137.96% | -854.11% | 114.87% | -310.01% |
| Safety | ||||
| Net Debt / EBITDA | -5.15 | -9.64 | -3.68 | -16.11 |
| Interest Coverage | 326.54 | 293.13 | 3,899.16 | 380.40 |
| Efficiency | ||||
| Inventory Turnover | 8.02 | 7.83 | 5.66 | 7.06 |
| Cash Conversion Cycle | 48.10 | 31.73 | -34.83 | -13.61 |